Zimmer Biomet paid $241M less to surgeons in 2020 — Here’s how 8 orthopedic companies compare

Orthopedic devicemakers’ general payments to surgeons plunged in 2020 compared to 2019 as elective surgeries and in-person visits were largely stunted because of the COVID-19 pandemic.

Advertisement

Here are surgeon payments for eight device companies in 2019 and 2020, according to CMS’ Open Payments Database:

1. Zimmer Biomet

2019: $303.9 million

2020: $62.9 million

Percentage change: (-79.3 percent)

2. Stryker

2019: $145.3 million

2020: $74.8 million

Percentage change: (-48.5 percent)

3. DePuy Synthes

2019: $135.5 million

2020: $65.6 million

Percentage change: (-51.6 percent)

4. Medtronic

2019: $82.5 million

2020: $67 million

Percentage change: (-18.8 percent)

5. Smith+Nephew

2019: $31.8 million

2020: $33.8 million

Percentage change: (+6.3 percent)

6. NuVasive

2019: $23.1 million

2020: $16.6 million

Percentage change: (-28.1 percent)

7. Globus Medical

2019: $15.8 million

2020: $12 million

Percentage change: (-24 percent)

8. Alphatec

2019: $5.6 million

2020: $6.3 million

Percentage change: (-12.5 percent)

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.